NEWARK, Calif.--(BUSINESS WIRE)--BioChain, a US-based company, said today Epigenomics AG of Germany seriously violated the terms of an ongoing licensing contract by publicly announcing on March 6, ...
Epigenomics AG: Resignation of Supervisory Board Chairman Heino von Prondzynski 27.01.2023 / 18:08 CET/CEST The issuer is solely responsible for the content of this announcement. Epigenomics AG: ...
EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual Report Epigenomics AG publishes financial results for fiscal year 2022 28.04.2023 / 08:00 CET/CEST The issuer is solely responsible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback